German Registry for Transcatheter Tricuspid Valve Interventions

NCT04653428 · tracked via the Priya Life Science Germany tracker

Sponsor

LMU Klinikum

Phase

Observational

Started

2020-10-01

Last updated

2020-12-04

Condition(s) studied

Tricuspid RegurgitationTricuspid Valve InsufficiencyHeart Valve

Investigational drug(s) / intervention(s)

Interventional treatment of tricuspid regurgitation

Interventional treatment of tricuspid regurgitation: Interventional treatment for tricuspid regurgitatin with CE-certified products, e.g. edge-to-edge repair

Study summary

Multicentre observational study of patients with severe tricuspid regurgitation and interventional treatment.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Interventional treatment of severe tricuspid regurgitation (isolated or in combination with another interventional treatment) with a CE certified product for tricuspid valve repair * Informed consent corresponding to criteria of Good Clinical Practice and the decleration of Helsinki as well as to standards of the local ethic commission. Exclusion Criteria: * No agreement to participation * Age \< 18 years

Primary outcome measure(s)

All-cause death and heart failure hospitalisation — 1 year
All-cause death and heart failure hospitalisation 1 year after transcatheter tricuspid valve treatment (TTVT)

Trial sites (1)

Facility	City	Region	Status
Klinikum der LMU Muenchen	Munich	Germany	Recruiting

More LMU Klinikum trials in Germany

Study to Examine Lesions of the Skin Using Confocal Laser Microscopy Active, not recruiting

TRICuspid Intervention and Invasive Hemodynamic Monitoring in Heart Failure Recruiting

TRICuspid Intervention in Heart Failure Trial Active, not recruiting

Assessment of Physical Activity and Cardiovascular Outcomes in Patients With Chronic Heart Failure Recruiting

Global Registry and Natural History Study for Mitochondrial Disorders Recruiting

Other trials for the same condition

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS) Recruiting

TARGET Study: Safety and Performance of the Cardiovalve TR Replacement System Active, not recruiting

TRILUMINATE Pivotal Trial Active, not recruiting

Transcatheter Repair of Tricuspid Regurgitation With Edwards PASCAL Transcatheter Valve Repair System Active, not recruiting

Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04653428 on ClinicalTrials.gov ↗ ← All trials in Germany